InvestorsHub Logo

davidal66

02/25/17 1:13 PM

#649 RE: davidal66 #648

1 more, interesting TVEC plus checkpoint inhibitor potentiating response of an approved viral therapy for melanoma... TVEC....

https://twitter.com/DrNDisis/status/835475521580515329/photo/1

gr8db8

02/25/17 5:38 PM

#651 RE: davidal66 #648

davidal66 ... cells (no matter mutant or not) have different surface receptors and different pathways / signaling / checkpoints so I think a combo ("cocktail") approach should be considered. Mutant cells seem to use different mechanisms to replicate and spread so attacking them from different directions would seem like a reasonable approach.

That's why I'm somewhat intrigued by VB-600 and its approach to cell motility.